Medical Devices Startups

STADA Arzneimittel AG is a pharmaceutical company based in Germany. No further business details provided on this investor relations contact page.

1 investor

Stago develops and manufactures hemostasis testing systems, analyzers, and reagents for clinical and laboratory diagnostics. Its products support blood coagulation and platelet function testing for laboratories, customers, and distributors.

1 investor

Stairway Medical develops medical devices and technologies to make procedural sedation safer and simpler, with a focus on preventing airway complications and enabling reliable breathing monitoring. The company serves healthcare providers and patients undergoing procedural sedation.

1 investor

Manufactures surgical instrument sets and tools for orthopedic procedures such as hip arthroscopy, including curettes, probes, rasps, tissue elevators, and suture manipulation devices.

1 investor

STARLIMS offers a laboratory informatics platform combining LIMS, ELN, SDMS, LES, and advanced analytics software for R&D, quality control, and manufacturing teams to accelerate product development and automate lab workflows. The platform serves pharmaceutical, biotech, and manufacturing organizations managing complex lab operations and compliance requirements.

1 investor

Starling Oncology delivers cancer treatment and clinical research services through a network of clinics and employed clinicians in community settings across multiple states. The company serves approximately 2.1 million patients with evidence-based oncology care, including chemotherapy, clinical trials, and supportive services.

1 investor

Star Syringe is a medical device licensing company that transfers its auto-disable (AD) syringe and needle-safety technology, including the K4 anti-needlestick safety needle cap, to manufacturers worldwide. Through its StarTek division it provides engineering, design, quality management, training, and turn-key factory solutions for producing medical disposable syringes and needles.

1 investor

The START Center for Cancer Research is a community-based early phase oncology research organization that runs clinical trials across a network of specialized units, having contributed to over 50 FDA/EMA-approved cancer therapies. It operates 15 research locations across the United States and Europe, working with community oncology centers, biopharma sponsors, and CROs.

1 investor

StataDx is developing a point-of-care diagnostic platform for neurology that measures multiple blood biomarkers (such as Neurofilament-light, pTau-217, GFAP, S100b, and UCH-L1) from a fingerprick whole blood sample. The system uses multiplexed cartridges with mobile and cloud connectivity for biomarker-guided disease management in clinics or at patients' homes.

1 investor

Stayble Therapeutics is a clinical-stage pharmaceutical company developing an injection-based treatment for disc herniation. The company is currently conducting phase 1b clinical trials for its therapeutic candidate.

1 investor

Steadiwear makes the Steadi-3 Plus, a battery-free anti-tremor glove that uses a magnetic vibration absorber to reduce hand tremors in real time. The FDA-registered Class I device is aimed at people with conditions like Essential Tremor to help with daily tasks such as writing, eating, and cooking.

1 investor

Steel Therapeutics is a pharmaceutical company that develops a pipeline of drug candidates and manages the associated regulatory, clinical, and product delivery work. It draws on pharmacy compounding and clinical trial expertise to bring medications to market.

1 investor

StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties. It supplies cells and cell expansion tools for stem cell research and regenerative medicine applications.

1 investor

StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis. The company targets immune disorders and tissue repair as unmet medical needs.

1 investor

Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.

1 investor

Stem Pharm develops therapeutics using stem cell technology for disease treatment and drug discovery. The company serves pharmaceutical and biotech partners seeking advanced cell-based approaches to translational drug development.

1 investor

StemSight develops stem cell-based therapies to restore sight, focusing on treatments for corneal conditions such as limbal stem cell deficiency using pluripotent stem cells. The company, spun out of the Skottman Lab's Eye Regeneration Group, targets patients with untreatable eye diseases in collaboration with cornea clinicians.

1 investor

STENTiT is a Dutch medtech company developing the Resorbable Fibrillated Scaffold (RFS), a device designed to trigger natural healing and reconstruct arteries for treating vascular conditions. The technology initially targets below-the-knee chronic limb threatening ischemia and has broader applications across endovascular treatments.

1 investor

Stereotaxis develops robotic systems for interventional medicine, focused on endovascular and cardiac procedures such as cardiac ablation. Its technology serves physicians and hospitals performing minimally invasive interventional treatments.

1 investor

StimAire develops wearable, wireless, and miniaturized medical solutions for treating obstructive sleep apnea. The company serves patients and combines clinical expertise with device technology in the sleep-medicine space.

1 investor

StimLabs develops regenerative medicine products, including its Corplex P device, used by physicians for wound healing and complex clinical cases. The company markets a portfolio of regenerative technologies for patient care.

1 investor

StimuSIL is a medical device company developing subdermal photobiomodulation technology that uses patented methods to deliver light-based stimulation beneath the skin's melanin layer for dermatology and aesthetics indications. Its lead preclinical candidate targets androgenetic alopecia (hair loss), with a research pipeline covering vitiligo, psoriasis, wrinkles, cellulite, and acne scars.

1 investor

STM develops microneedle patch technology for painless, temperature-stable delivery of drugs, vaccines, and supplements to humans, animals, and for nutraceutical applications. The platform eliminates cold-chain storage requirements and enables single-application multi-dose delivery across therapeutic and preventative use cases.

1 investor

Strand AI predicts missing biological data modalities from existing patient data, converting single histopathology slides into spatial protein maps and inferring gene expression from genotype. The platform serves researchers and clinicians in computational pathology and genomics.

1 investor